Research by Sheng et al. (Sheng et al., 2016) revealed the downregulation of PD-L1 expression in tumor cells of NSCLC patients after treatment with neoadjuvant chemotherapy (paclitaxel, pemetrex, and TKI). The gene discussed is CD274; the disease is neoplasm.